SLC2A3 and chronic obstructive pulmonary disease: Our analysis, which focused on the immune microenvironment of COPD patients, revealed that SLC2A3 was expressed in macrophages from COPD patients and was upregulated in THP-M cells and lung tissues of these patients (Zhang et al., 2023).